Many observational studies investigated the association between FGF23 and various cardiovascular adverse events in CKD [5] like left ventricular hypertrophy [6], vascular calcification [7], and increased risk of ischemic heart and brain insults [8]. The gene discussed is FGF23; the disease is chronic kidney disease.